Pulmuone Co Ltd
KRX:017810

Watchlist Manager
Pulmuone Co Ltd Logo
Pulmuone Co Ltd
KRX:017810
Watchlist
Price: 10 090 KRW 0.4% Market Closed
Market Cap: ₩384.6B

Wall St Price Targets

Price Targets Summary
Pulmuone Co Ltd

Wall Street analysts forecast Pulmuone Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Pulmuone Co Ltd is 17 340 KRW with a low forecast of 17 170 KRW and a high forecast of 17 850 KRW.

Lowest Forecast
Price Target
17 170 KRW
70% Upside
Average Forecast
Price Target
17 340 KRW
72% Upside
Highest Forecast
Price Target
17 850 KRW
77% Upside
Pulmuone Co Ltd Competitors:
Price Targets
8595
JAFCO Group Co Ltd
8% Upside
PFBC
Preferred Bank
8% Upside
JEN
Jensen-Group NV
-10% Downside

Revenue
Forecast

7% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
7% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 2 years is 7%.

Gross Profit
Forecast

6% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
6% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 2 years is 7%.

Operating Income
Forecast

5% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
5% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 2 years is 22%.

Pre-Tax Income
Forecast

1% / Year
Past Growth
66% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss
1% / Year
Past Growth
66% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 2 years is 66%.

Net Income
Forecast

-11% / Year
Past Growth
347% / Year
Estimated Growth
Estimates Accuracy
-32%
Average Miss
-11% / Year
Past Growth
347% / Year
Estimated Growth
Estimates Accuracy
-32%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been -11%. The projected CAGR for the next 2 years is 347%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Pulmuone Co Ltd's stock price target?
Price Target
17 340 KRW

According to Wall Street analysts, the average 1-year price target for Pulmuone Co Ltd is 17 340 KRW with a low forecast of 17 170 KRW and a high forecast of 17 850 KRW.

What is the Revenue forecast for Pulmuone Co Ltd?
Projected CAGR
7%

Over the last 14 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 2 years is 7%.

What is the Gross Profit forecast for Pulmuone Co Ltd?
Projected CAGR
7%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 2 years is 7%.

What is the Operating Income forecast for Pulmuone Co Ltd?
Projected CAGR
22%

Over the last 14 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 2 years is 22%.

What is the Pre-Tax Income forecast for Pulmuone Co Ltd?
Projected CAGR
66%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 2 years is 66%.

What is the Net Income forecast for Pulmuone Co Ltd?
Projected CAGR
347%

Over the last 14 years, the compound annual growth rate for Net Income has been -11%. The projected CAGR for the next 2 years is 347%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett